Stirling fishes for trout

By Dylan Bushell-Embling
Tuesday, 15 July, 2008

Stirling Products North America, a subsidiary of Perth's Stirling Products [ASX: STI] has demonstrated the results of its research into treatment of Loma microsporidial gill disease at an American Fisheries Society meeting.

Loma gill disease, caused by Loma salmonae, is an untreatable disease commonly found in farmed fish, particularly in Pacific salmon and trout.

Research conducted by Stirling demonstrates that the company's ProVale product was more effective at inhibiting Loma infection in rainbow trout when compared with unlicensed products.

ProVale is a beta glucan extract designed to stimulate the immune system.

Related News

Cannabis use may double risk of cardiovascular disease death

Cannabis users have a 29% higher risk of acute coronary syndrome, a 20% higher risk of stroke,...

Space conditions can lead to periodontitis, scientists say

Living in zero gravity can lead to periodontitis — a serious condition where the gums...

Personalised brain stimulation helps treat those with depression

By tailoring transcranial magnetic stimulation to each person's unique brain structure,...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd